High-level expression of recombinant human nerve growth factor beta in milk of nontransgenic rabbits

Journal of Bioscience and Bioengineering

Volumn 105, Issue 4, 2008, Pages 327-334

  Xiao, Bo ^a,c   Li, Qing Wang ^a,b   Feng, Bo ^a   Han, Zeng Sheng ^b   Gao, Da Wei ^b   Li, Jian ^b   Li, Kun ^b   Zhao, Rui ^b   Jiang, Zhong Liang ^a   Hu, Jian Hong ^a   Zhi, Xu Bo ^a  

^a NORTHWEST A F UNIVERSITY   (China)

^b YANSHAN UNIVERSITY   (China)

^c LUDONG UNIVERSITY   (China)

Author keywords

adenovirus; human nerve growth factor beta; mammary gland; milk; nerve growth factor; recombinant protein

Indexed keywords

BIOACTIVITY; DRUG PRODUCTS PLANTS; GENE EXPRESSION; MAMMALS; NEURONS; POLYPEPTIDES;

ADENOVIRAL EXPRESSION; GANGLIONIC NEURONS; HUMAN NERVE GROWTH FACTOR BETA; MAMMARY GLANDS;

CELL GROWTH;

NERVE GROWTH FACTOR BETA SUBUNIT; POLYPEPTIDE; RECOMBINANT NERVE GROWTH FACTOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHICK EMBRYO; CONTROLLED STUDY; EMBRYO; FEMALE; MAMMARY GLAND; MILK; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; RABBIT; SPINAL GANGLION; VIRUS EXPRESSION; WESTERN BLOTTING;

ADENOVIRIDAE; ANIMALS; CHICK EMBRYO; FEMALE; GANGLIA, SPINAL; GENE EXPRESSION; HUMANS; MAMMARY GLANDS, ANIMAL; MILK; NERVE GROWTH FACTOR; PC12 CELLS; RABBITS; RATS; RECOMBINANT PROTEINS; TRANSDUCTION, GENETIC;

ADENOVIRIDAE; MAMMALIA; ORYCTOLAGUS CUNICULUS;

EID: 43549111181     PISSN: 13891723     EISSN: None     Source Type: Journal    
DOI: 10.1263/jbb.105.327     Document Type: Article

References (54)

1. Levi-Montalcini R., Skaper S.D., Dal Toso R., Petrelli L., and Leon A. Nerve growth factor: from neurotrophin to neurokine. Trends Neurosci. 19 (1996) 514-520
2. Villoslada P., Hauser S.L., Bartke I., Unger J., Heald N., Rosenberg D., Cheung S.W., Mobley W.C., Fisher S., and Genain C.P. Human nerve growth factor protects common marmosets against autoimmune encephalomyelitis by switching the balance of T helper cell type 1 and 2 cytokines within the central nervous system. J. Exp. Med. 191 (2000) 1799-1806
3. Tuszynski M.H. Growth-factor gene therapy for neurodegenerative disorders. Lancet Neurol. 1 (2002) 51-57
4. De Rosa R., Garcia A.A., Braschi C., Capsoni S., Maffei L., Berardi N., and Cattaneo A. Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice. Proc. Natl. Acad. Sci. USA 102 (2005) 3811-3816
5. Yuen E.C., Howe C.L., Li Y., Holtzman D.M., and Mobley W.C. Nerve growth factor and the neurotrophic factor hypothesis. Brain Dev. 18 (1996) 362-368
6. Hefti F. Neurotrophic factor therapy for nervous system degenerative diseases. J. Neurobiol. 25 (1994) 1418-1435
7. Muangman P., Muffley L.A., Anthony J.P., Spenny M.L., Underwood R.A., Olerud J.E., and Gibran N.S. Nerve growth factor accelerates wound healing in diabetic mice. Wound Repair Regen. 12 (2004) 44-52
8. Kawamoto K., and Matsuda H. Nerve growth factor and wound healing. Prog. Brain. Res. 146 (2004) 369-384
9. Conner J.M., Fass-Holmes B., and Varon S. Changes in nerve growth factor immunoreactivity following entorhinal cortex lesions: possible molecular mechanism regulating cholinergic sprouting. J. Comp. Neurol. 345 (1994) 409-418
10. Fischer W., Wictorin K., Bjorklund A., Williams L.R., Varon S., and Gage F.H. Melioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature 329 (1987) 65-68
11. Fischer W. Nerve growth factor reverses spatial memory impairments in aged rats. Neurochem. Int. 25 (1994) 47-52
12. Markowska A.L., Koliatsos V.E., Breckler S.J., Price D.L., and Olton D.S. Human nerve growth factor improves spatial memory in aged but not in young rats. J. Neurosci. 14 (1994) 4815-4824
13. Pizzo D.P., and Thal L.J. Intraparenchymal nerve growth factor improves behavioral deficits while minimizing the adverse effects of intracerebroventricular delivery. Neuroscience 24 (2004) 743-755
14. Jakubowska-Dogru E., and Gumusbas U. Chronic intracerebroventricular NGF administration improves working memory in young adult memory deficient rats. Neurosci. Lett. 382 (2005) 45-50
15. Missale C., and Spano P. Nerve growth factor in pituitary development and pituitary tumors. Front Neuroendocrinol. 19 (1998) 128-150
16. Frade J.M., and Barde Y.A. Nerve growth factor: two receptors, multiple functions. Bioessays 20 (1998) 137-145
17. Rogers B.C. Development of recombinant human nerve growth factor (rhNGF-β) as a treatment for peripheral neuropathic disease. Neurotoxicology 17 (1996) 865-870
18. Scott S.A., and Crutcher K.A. Nerve growth factor and Alzheimer's disease. Rev. Neurosci. 5 (1994) 179-211
19. Bernabei R., Landi F., Bonini S., Onder G., Lambiase A., Pola R., and Aloe L. Effect of topical application of nerve-growth factor on pressure ulcers. Lancet 354 (1999) 307
20. Tuveri M., Generini S., Matucci-Cerinic M., and Aloe L. NGF, a useful tool in the treatment of chronic vasculitic ulcers in rheumatoid arthritis. Lancet 356 (2000) 1739-1740
21. Lambiase A., Manni L., Rama P., and Bonini S. Clinical application of nerve growth factor on human corneal ulcer. Arch. Ital. Biol. 141 (2003) 141-148
22. Tan M.H., Bryars J., and Moore J. Use of nerve growth factor to treat congenital neurotrophic corneal ulceration. Cornea 25 (2006) 352-355
23. Lambiase A., Coassin M., Sposato V., Micera A., Sacchetti M., Bonini S., and Aloe L. NGF topical application in patients with corneal ulcer does not generate circulating NGF antibodies. Pharmacol. Res. 56 (2007) 65-69
24. Fujimori K., Fukuzono S., Kotomura N., Kuno N., and Shimizu N. Overproduction of biologically-active human nerve growth factor in Escherichia coli. Biosci. Biotechnol. Biochem. 56 (1992) 1985-1990
25. Zhang J., Zhang L., Zhang X., Chai J., and Li C. The high expression of human beta-nerve growth factor in E. coli. Wei Sheng Wu Xue Bao 37 (1997) 429-433
26. Nishizawa M., Ozawa F., Higashizaki T., Hirai K., and Hishinuma F. Biologically active human and mouse nerve growth factors secreted by the yeast Saccharomyces cerevisiae. Appl. Microbiol. Biotechnol. 38 (1993) 624-630
27. Nguyen B., Jarnagin K., Williams S., Chan H., and Barnett J. Fed-batch culture of insect cells: a method to increase the yield of recombinant human nerve growth factor (rhNGF-β) in the baculovirus expression system. J. Biotechnol. 31 (1993) 205-217
28. Bruce G., and Heinrich G. Production and characterization of biologically active recombinant human nerve growth factor. Neurobiol. Aging 10 (1989) 89-94
29. Iwane M., Kitamura Y., Kaisho Y., Yoshimura K., Shintani A., Sasada R., Nakagawa S., Kawahara K., Nakahama K., and Kakinuma A. Production, purification and characterization of biologically active recombinant human nerve growth factor. Biochem. Biophys. Res. Commun. 171 (1990) 116-122
30. Schmelzer C.H., Burton L.E., Chan W.P., Martin E., Gorman C., Canova-Davis E., Ling V.T., Sliwkowski M.B., McCray G., Briggs J.A., Nguyen T.H., and Polastri G. Biochemical characterization of recombinant human nerve growth factor. J. Neurochem. 59 (1992) 1675-1683
31. Coulibaly S., Besenfelder U., Fleischmann M., Zinovieva N., Grossmann A., Wozny M., Bartke I., Togel M., Muller M., and Brem G. Human nerve growth factor beta (hNGF-beta): mammary gland specific expression and production in transgenic rabbits. FEBS Lett. 444 (1999) 111-116
32. Werner R.G. Innovative and economic potential of mammalian cell culture. Arzneimittelforschung 48 (1998) 423-426
33. Patton S., Welsch U., and Singh S. Intramammary infusion technique for genetic engineering of the mammary gland. J. Dairy. Sci. 67 (1984) 1323-1326
34. Yang J., Tsukamoto T., Popnikolov N., Guzman R.C., Chen X., Yang J.H., and Nandi S. Adenoviral-mediated gene transfer into primary human and mouse mammary epithelial cells in vitro and in vivo. Cancer Lett. 98 (1995) 9-17
35. Wagner K.U., Wall R.J., St-Onge L., Gruss P., Wynshaw-Boris A., Garrett L., Li M., Furth P.A., and Hennighausen L. Cre-mediated gene deletion in the mammary gland. Nucleic Acids Res. 25 (1997) 4323-4330
36. Jeng M.H., Kao C., Sivaraman L., Krnacik S., Chung L.W., Medina D., Conneely O.M., and Malley B.W.O. Reconstitution of estrogendependent transcriptional activation of an adenoviral target gene in select regions of the rat mammary gland. Endocrinology 39 (1998) 2916-2925
37. Russell T.D., Fischer A., Beeman N.E., Freed E.F., Neville M.C., and Schaack J. Transduction of the mammary epithelium with adenovirus vectors in vivo. J. Virol. 77 (2003) 5801-5809
38. Fan W., Plaut K., Bramley A.J., Barlow J.W., Mischler S.A., and Kerr D.E. Persistency of adenoviral-mediated lysostaphin expression in goat mammary glands. J. Dairy Sci. 87 (2004) 602-608
39. Sanchez O., Toledo J.R., Rodriguez M.P., and Castro F.O. Adenoviral vector mediates high expression levels of human growth hormone in the milk of mice and goats. J. Biotechnol. 114 (2004) 89-97
40. Toledo J.R., Sanchez O., Montesino S.R., Fernandez G.Y., Rodriguez M.P., and Cremata J.A. Differential in vitro and in vivo glycosylation of human erythropoietin expressed in adenovirally transduced mouse mammary epithelial cells. Biochim. Biophys. Acta 1726 (2005) 48-56
41. Toledo J.R., Sanchez O., Segui R.M., Garcia G., Montanez M., Zamora P.A., Rodriguez M.P., and Cremata J.A. High expression level of recombinant human erythropoietin in the milk of non-transgenic goats. J. Biotechnol. 123 (2006) 225-235
42. Ausubel F.M., Brent R., Kingston R.E., Moore D.D., Seidman J.G., Smith J.A., and Struhl K. Current protocols in molecular biology (1993), Greene Publishing Associates, New York
43. Sambrook J., Fritsch E.F., and Maniatis T. Molecular cloning: a laboratory manual (1989), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York
44. He T.C., Zhou S., da Costa L.T., Yu J., Kinzler K.W., and Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA 95 (1998) 2509-2514
45. Han Z.S., Li Q.W., Zhang Z.Y., Xiao B., Gao D.W., Wu S.Y., Li J., Zhao H.W., Jiang Z.L., and Hu J.H. High-level expression of human lactoferrin in the milk of goats by using replication-defective adenoviral vectors. Protein Expr. Purif. 53 (2007) 225-231
46. Levi-Montalcini R. Effects of mouse tumor transplantation on the nervous system. Ann. NY Acad. Sci. 55 (1952) 330-344
47. Scott J., Selby M., Urdea M., Quiroga M., Bell G.I., and Rutter W.J. Isolation and nucleotide sequence of a cDNA encoding the precursor of mouse nerve growth factor. Nature 302 (1983) 538-540
48. Borsani G., Pizzuti A., Rugarli E.I., Falini A., Scarlato G., Baralle F.E., and Silani V. Human fetal brain beta-nerve growth factor cDNA: molecular cloning of 5′ and 3′ untranslated regions. Neurosci. Lett. 127 (1991) 117-120
49. Song M., and Chen S.Z. Construction of the eukaryotic expression vector of mouse beta-NGF and its expression in NIH 3T3 fibroblast cell lines. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 19 (2003) 124-126
50. Hitt M.M., Addison C.L., and Graham F.L. Human adenovirus vectors for gene transfer into mammalian cells. Adv. Pharmacol. 40 (1997) 137-206
51. Kovesdi I., Brough D.E., Bruder J.T., and Wickham T.J. Adenoviral vectors for gene transfer. Curr. Opin. Biotechnol. 8 (1997) 583-589
52. Danthinne X., and Imperiale M.J. Production of first generation adenovirus vectors: a review. Gene Ther. 7 (2000) 1707-1714
53. Oualikene W., and Massie B. Adenovirus vectors in functional genomics. In: Rubeai A. (Ed). Cell engineering vol. 2 (2000), Kluwer, Dordrecht, The Netherlands 80-154
54. Wang I.I., and Huang I.I. Adenovirus technology for gene manipulation and functional studies. Drug Discov. Today 5 (2000) 10-16